160 related articles for article (PubMed ID: 21732775)
21. Evaluation of a Rapid, Fully Automated Platform for Detection of BRAF and NRAS Mutations in Melanoma.
Barel F; Guibourg B; Lambros L; Le Flahec G; Marcorelles P; Uguen A
Acta Derm Venereol; 2018 Jan; 98(1):44-49. PubMed ID: 28660280
[TBL] [Abstract][Full Text] [Related]
22. Somatic alterations in the melanoma genome: a high-resolution array-based comparative genomic hybridization study.
Gast A; Scherer D; Chen B; Bloethner S; Melchert S; Sucker A; Hemminki K; Schadendorf D; Kumar R
Genes Chromosomes Cancer; 2010 Aug; 49(8):733-45. PubMed ID: 20544847
[TBL] [Abstract][Full Text] [Related]
23. A HRM assay for identification of low level BRAF V600E and V600K mutations using the CADMA principle in FFPE specimens.
Huebner C; Weber R; Lloydd R
Pathology; 2017 Dec; 49(7):776-783. PubMed ID: 29100713
[TBL] [Abstract][Full Text] [Related]
24. Molecular biology methods to improve diagnosis and prognosis of melanocytic tumors.
Wiesner T; Fried I; Cerroni L; Kutzner H
J Dtsch Dermatol Ges; 2013 May; 11 Suppl 4():19-24. PubMed ID: 23721637
[No Abstract] [Full Text] [Related]
25. Practical application of new technologies for melanoma diagnosis: Part II. Molecular approaches.
March J; Hand M; Truong A; Grossman D
J Am Acad Dermatol; 2015 Jun; 72(6):943-58; quiz 959-60. PubMed ID: 25980999
[TBL] [Abstract][Full Text] [Related]
26. Molecular platforms utilized to detect BRAF V600E mutation in melanoma.
Curry JL; Torres-Cabala CA; Tetzlaff MT; Bowman C; Prieto VG
Semin Cutan Med Surg; 2012 Dec; 31(4):267-73. PubMed ID: 23174497
[TBL] [Abstract][Full Text] [Related]
27. Dual NRASQ61R and BRAFV600E mutation-specific immunohistochemistry completes molecular screening in melanoma samples in a routine practice.
Uguen A; Guéguen P; Legoupil D; Bouvier S; Costa S; Duigou S; Lemasson G; Ledé F; Sassolas B; Talagas M; Férec C; Le Maréchal C; De Braekeleer M; Marcorelles P
Hum Pathol; 2015 Nov; 46(11):1582-91. PubMed ID: 26297254
[TBL] [Abstract][Full Text] [Related]
28. MicroRNA expression in melanocytic nevi: the usefulness of formalin-fixed, paraffin-embedded material for miRNA microarray profiling.
Glud M; Klausen M; Gniadecki R; Rossing M; Hastrup N; Nielsen FC; Drzewiecki KT
J Invest Dermatol; 2009 May; 129(5):1219-24. PubMed ID: 19005486
[TBL] [Abstract][Full Text] [Related]
29. Molecular techniques for predicting behaviour in melanocytic neoplasms.
Lee CY; Gerami P
Pathology; 2016 Feb; 48(2):142-6. PubMed ID: 27020386
[TBL] [Abstract][Full Text] [Related]
30. BRAF mutation: a frequent event in benign, atypical, and malignant melanocytic lesions of the skin.
Uribe P; Wistuba II; González S
Am J Dermatopathol; 2003 Oct; 25(5):365-70. PubMed ID: 14501284
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of BRAF mutation testing methodologies in formalin-fixed, paraffin-embedded cutaneous melanomas.
Lade-Keller J; Rømer KM; Guldberg P; Riber-Hansen R; Hansen LL; Steiniche T; Hager H; Kristensen LS
J Mol Diagn; 2013 Jan; 15(1):70-80. PubMed ID: 23159593
[TBL] [Abstract][Full Text] [Related]
32. [Characterization of genetic alterations in primary human melanomas carrying BRAF or NRAS mutation].
Lázár V
Magy Onkol; 2013 Jun; 57(2):96-9. PubMed ID: 23795354
[TBL] [Abstract][Full Text] [Related]
33. BRAF mutations distinguish anorectal from cutaneous melanoma at the molecular level.
Helmke BM; Mollenhauer J; Herold-Mende C; Benner A; Thome M; Gassler N; Wahl W; Lyer S; Poustka A; Otto HF; Deichmann M
Gastroenterology; 2004 Dec; 127(6):1815-20. PubMed ID: 15578519
[TBL] [Abstract][Full Text] [Related]
34. Molecular genetic classification of difficult melanocytic tumors.
Metzler G; Eigentler TK; Held L; Kind P; Hantschke M; Garbe C; Bauer J
J Dtsch Dermatol Ges; 2013 May; 11 Suppl 4():11-8. PubMed ID: 23721635
[No Abstract] [Full Text] [Related]
35. Marked genetic differences between BRAF and NRAS mutated primary melanomas as revealed by array comparative genomic hybridization.
Lázár V; Ecsedi S; Vízkeleti L; Rákosy Z; Boross G; Szappanos B; Bégány A; Emri G; Adány R; Balázs M
Melanoma Res; 2012 Jun; 22(3):202-14. PubMed ID: 22456166
[TBL] [Abstract][Full Text] [Related]
36. Molecular aspects of melanoma.
Da Forno PD; Saldanha GS
Clin Lab Med; 2011 Jun; 31(2):331-43. PubMed ID: 21549246
[TBL] [Abstract][Full Text] [Related]
37. Melanoma genomics.
Kashani-Sabet M
Curr Oncol Rep; 2004 Sep; 6(5):401-5. PubMed ID: 15291985
[TBL] [Abstract][Full Text] [Related]
38. Targeted Genomic Profiling of Acral Melanoma.
Yeh I; Jorgenson E; Shen L; Xu M; North JP; Shain AH; Reuss D; Wu H; Robinson WA; Olshen A; von Deimling A; Kwok PY; Bastian BC; Asgari MM
J Natl Cancer Inst; 2019 Oct; 111(10):1068-1077. PubMed ID: 30657954
[TBL] [Abstract][Full Text] [Related]
39. [Molecular diagnostics of melanomas].
Griewank KG
Pathologe; 2015 Feb; 36(1):30-6. PubMed ID: 25491471
[TBL] [Abstract][Full Text] [Related]
40. Fast Diagnostics of BRAF Mutations in Biopsies from Malignant Melanoma.
Huber F; Lang HP; Glatz K; Rimoldi D; Meyer E; Gerber C
Nano Lett; 2016 Sep; 16(9):5373-7. PubMed ID: 27490749
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
